These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 2144979)
1. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741. Schumacher WA; Heran CL; Ogletree ML Eicosanoids; 1990; 3(2):87-93. PubMed ID: 2144979 [TBL] [Abstract][Full Text] [Related]
2. Protamine-heparin-induced pulmonary hypertension in pigs: effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation. Nuttall GA; Murray MJ; Bowie EJ Anesthesiology; 1991 Jan; 74(1):138-45. PubMed ID: 1824742 [TBL] [Abstract][Full Text] [Related]
3. Activity of the short-acting thromboxane receptor antagonist, SQ 30,741, in thrombolytic and vasospastic models in monkeys. Schumacher WA; Heran CL; Hartl KS; Ogletree ML J Pharmacol Exp Ther; 1990 May; 253(2):841-6. PubMed ID: 2140131 [TBL] [Abstract][Full Text] [Related]
4. Thromboxane receptor activation during bronchospasm induced by platelet-activating factor. Schumacher WA; Steinbacher TE J Lipid Mediat; 1991; 4(1):97-110. PubMed ID: 1832573 [TBL] [Abstract][Full Text] [Related]
5. [Losartan prevents pulmonary hypertension induced by a thromboxane A2 analog]. Bertolino F; Valentin JP; Maffre M; Jover B; Bessac AM; John GW Arch Mal Coeur Vaiss; 1994 Aug; 87(8):971-4. PubMed ID: 7755474 [TBL] [Abstract][Full Text] [Related]
6. Antithrombotic effects of the thromboxane A2 antagonist, SQ 28,668, in vitro and in the coronary circulation in vivo. Ogletree ML; Harris DN; Heran CL; Phillips MB; Michel IM; Goldenberg HJ Eicosanoids; 1988; 1(2):85-91. PubMed ID: 2856188 [TBL] [Abstract][Full Text] [Related]
7. Prostaglandin B2-induced pulmonary hypertension is mediated by TxA2/PGH2 receptor stimulation. Liu F; Orr JA; Wu JY Am J Physiol; 1994 Nov; 267(5 Pt 1):L602-8. PubMed ID: 7977770 [TBL] [Abstract][Full Text] [Related]
8. Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs. Conzen PF; Habazettl H; Gutmann R; Hobbhahn J; Goetz AE; Peter K; Brendel W Anesth Analg; 1989 Jan; 68(1):25-31. PubMed ID: 2910134 [TBL] [Abstract][Full Text] [Related]
9. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate. Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331 [TBL] [Abstract][Full Text] [Related]
10. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets. Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275 [TBL] [Abstract][Full Text] [Related]